KAPA vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

KAPA

44.7
AI Score
VS
NIVF Wins

NIVF

45.6
AI Score

Investment Advisor Scores

KAPA

45score
Recommendation
HOLD

NIVF

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric KAPA NIVF Winner
Forward P/E 0 0.06 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 11.9% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.7/100 45.6/100 NIVF
Profit Margin 0.0% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

KAPA 1M: -15.8% · 3M: -45.0% NIVF 1M: +41.4% · 3M: -61.9%

Current Technical Phase

KAPA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.0%), weak momentum, RSI 42

RSI (14): 41.6 · Price: $0.31

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.2 · Price: $0.65

Fundamentals Snapshot

Metric KAPA NIVF
Market Cap
Forward P/E -0.5 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2%
Operating Margin 0.0% -3.5%
EPS -0.30 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.